article thumbnail

Assessment of Project ECHO(R) Opioid Use Disorder Sessions for Primary Care Teams [Education and training]

Annals of Family Medicine

Unfortunately, most individuals suffering from OUD do not have access to necessary care. Non-parametric tests were used to compare individual responses before and after participation, as well as responses between different participant group. Intervention: 12 monthly online OUD sessions held from April 2023 to March 2024.

article thumbnail

Hepatitis C Micro-elimination Using Patient Navigation In a Regional Healthcare System [Infectious diseases (not respiratory tract)]

Annals of Family Medicine

Micro-elimination projects aim to selectively foster diagnosis, treatment and reinfection of high priority demographic groups. A small-scale, peer navigation focused micro-elimination project was launched to facilitate treatment engagement and re-testing for individuals experiencing elevated risk of HCV re-infection.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The utilization patterns and impact of the Stanford Chronic Pain Self-Management Program in Eastern Ontario, Canada [Pain management]

Annals of Family Medicine

Dataset: We used data routinely collected through the CPSMP between December 2017 and May 2023. Population studied: The CPSMP targeted individuals suffering from chronic pain in the Champlain region of Eastern Ontario. Intervention: The CPSMP is a six-week, peer-led program based on self-efficacy theory.

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog

11, 2023 ( DOJ Press Release ). 6, 2023 ( DOJ Press Release ). Pharmacists’ Corresponding Responsibility A controlled substance prescription, to be valid, must be issued for “a legitimate medical purpose by an individual practitioner acting in the usual course of [their] professional practice.” Complaint ¶ 58. Complaint ¶ 59.

article thumbnail

A Long Time Coming: DEA Regs Finally Authorize Schedule II Prescription Partial Fills

FDA Law Blog

Now, in July 2023, DEA has finally issued its final rule amending its regulations for partial filling of prescriptions for schedule II substances. 46,983 (July 21, 2023). Partial Filling of Prescriptions for Schedule II Controlled Substances, 85 Fed. 78,282 (Dec. The Final Rule a. b)(5)(i)). (2) codified at 21 C.F.R. b)(5)(ii)).

article thumbnail

Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders

FDA Law Blog

For a controlled substance prescription to be effective, that is valid, it must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of their professional practice. 81, 86, 251. 81, 89, 251.

article thumbnail

Parvo Podcast! Erythema Infectiosum, Fifth Disease, and more!

PEMBlog

Clinical Manifestations and Diagnosis of Parvovirus B19 Infection. Only about 25% of infected individuals will have this classic rash syndrome. Diagnosis is confirmed with PCR, often as part of a viral panel, or via characteristic bone marrow findings. Its a clinical diagnosis, especially in typical cases. UpToDate , Jun.